State Of Wyoming Revance Therapeutics, Inc. Transaction History

State Of Wyoming

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$11.52 - $20.4 $141,246 - $250,124	-12,261 Closed	0 $0
Q1 2022 May 13, 2022	BUY	$12.36 - $20.31 $40,652 - $66,799	3,289 Added 36.66%	12,261 $239,000
Q4 2021 Feb 11, 2022	BUY	$12.46 - $27.87 $6,927 - $15,495	556 Added 6.61%	8,972 $146,000
Q3 2021 Feb 11, 2022	SELL	$25.78 - $33.21 $4,691 - $6,044	-182 Reduced 2.12%	8,416 $234,000
Q2 2021 Feb 11, 2022	BUY	$26.8 - $31.84 $230,426 - $273,760	8,598 New	8,598 $255,000

234

82.8M

680K

896K

Ticker RVNC
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 82,305,696
Market Cap $212M
Description
Revance Therapeutics, Inc., a biotechnology company, engages in the development, manufacture, and commercialization of neuromodulators for various aesthetic and therapeutic indications in the United States and internationally. The company's lead drug candidate is DaxibotulinumtoxinA for injection, which has completed phase III clinical trials fo...

Get notified when there are updates to the investment portfolio of State Of Wyoming, based on Form 13F filings with the SEC.

Stay updated on State Of Wyoming with notifications on news.